BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7118412)

  • 1. Solid-phase synthesis of peptides via alpha, beta-unsaturated amino acids: oxytocin, simultaneous incorporation of amide functions in COOH-terminal and endo-positions.
    Noda K; Gazis D; Gross E
    Int J Pept Protein Res; 1982 Apr; 19(4):413-9. PubMed ID: 7118412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermolysin as a catalyst in enzymatic synthesis of asparagine-containing peptides II.
    Miranda MT; Tominaga M
    Int J Pept Protein Res; 1991 Feb; 37(2):128-33. PubMed ID: 2019475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of oxytocin using iodine for oxidative cyclization and silica gel adsorption chromatography for purification.
    Flouret G; Terada S; Kato T; Gualtieri R; Lipkowski A
    Int J Pept Protein Res; 1979 Feb; 13(2):137-41. PubMed ID: 429090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [1-Deaminopenicillamine,4-threonine]oxytocin, a potent inhibitor of oxytocin.
    Manning M; Lowbridge J; Seto J; Haldar J; Sawyer WH
    J Med Chem; 1978 Feb; 21(2):179-82. PubMed ID: 621712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and some pharmacological properties of oxytocin analogues having L-thiazolidine-4-carboxylic acid in position 7.
    Rosamond JD; Ferger MF
    J Med Chem; 1976 Jul; 19(7):873-6. PubMed ID: 940106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [1-Beta-mercapto-beta,beta-pentamethylenepropionic acid]oxytocin, a potent inhibitor of oxytocin.
    Nestor JJ; Ferger MF; du Vigneaud V
    J Med Chem; 1975 Mar; 18(3):284-7. PubMed ID: 1133819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological properties of [1-L-penicillamine,4-L-leucine]oxytocin.
    Ferger MF; Chan WY
    J Med Chem; 1975 Oct; 18(10):1020-2. PubMed ID: 1159679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (4-Phenylalanine)oxytocin, an inhibitor of the antidiuretic effect of 8-arginine-vasopressin.
    Nestor JJ; Ferger MF; Chan WY
    J Med Chem; 1975 Oct; 18(10):1022-4. PubMed ID: 1159680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis by conventional methods of human growth hormone peptide fragments. I.
    Chellemi F
    Int J Pept Protein Res; 1975; 7(2):143-8. PubMed ID: 1140885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid-phase synthesis with attachment of peptide to resin through an amino acid side chain: (8-lysine)-vasopressin.
    Meienhofer J; Trzeciak A
    Proc Natl Acad Sci U S A; 1971 May; 68(5):1006-9. PubMed ID: 5280519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient access to enantiopure γ4-amino acids with proteinogenic side-chains and structural investigation of γ4-Asn and γ4-Ser in hybrid peptide helices.
    Jadhav SV; Misra R; Singh SK; Gopi HN
    Chemistry; 2013 Nov; 19(48):16256-62. PubMed ID: 24151124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-Phase Total Synthesis of Bacitracin A.
    Lee J; Griffin JH; Nicas TI
    J Org Chem; 1996 Jun; 61(12):3983-3986. PubMed ID: 11667271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary structure of murine major histocompatibility complex alloantigens: amino acid sequence of the amino-terminal one hundred and seventy-three residues of the H-2Kb glycoprotein.
    Uehara H; Ewenstein BM; Martinko JM; Nathenson SG; Coligan JE; Kindt TJ
    Biochemistry; 1980 Jan; 19(2):306-15. PubMed ID: 6986168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of asparagine and glutamine during N alpha-Bpoc-based solid-phase peptide synthesis.
    Carey RI; Huang H; Wadsworth JL; Burrell CS
    Int J Pept Protein Res; 1996 Mar; 47(3):209-13. PubMed ID: 8740971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthesis and 13C-NMR spectra of the N-terminal decapeptide sequence of human lymphoblast interferon].
    Jung G; Brückner H
    Hoppe Seylers Z Physiol Chem; 1981 Mar; 362(3):291-304. PubMed ID: 6164624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asparagine coupling in Fmoc solid phase peptide synthesis.
    Gausepohl H; Kraft M; Frank RW
    Int J Pept Protein Res; 1989 Oct; 34(4):287-94. PubMed ID: 2599767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative solid-phase Edman degradation for evaluation of extended solid-phase peptide synthesis.
    Matsueda GR; Haber E; Margolies MN
    Biochemistry; 1981 Apr; 20(9):2571-80. PubMed ID: 6786336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and some pharmacological properties of [1-beta-mercapto-beta,beta-diethylpropionic acid,2-(3,5-dibromo-L-tyrosine)]oxytocin.
    Lundell EO; Smith CW; Ferger MF
    J Med Chem; 1975 Dec; 18(12):1262-4. PubMed ID: 1195281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facile SPS of peptides having C-terminal Asn and Gln.
    Breipohl G; Knolle J; Stüber W
    Int J Pept Protein Res; 1990 Mar; 35(3):281-3. PubMed ID: 2354879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.